Page 7 - கேடோஸ் அடிப்படையிலானது அர்ஸ் ப்யாக்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேடோஸ் அடிப்படையிலானது அர்ஸ் ப்யாக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேடோஸ் அடிப்படையிலானது அர்ஸ் ப்யாக்ஸ் Today - Breaking & Trending Today

Los Gatos Hate Crimes Meeting Takes Unexpected Turn


UpdatedThu, Apr 8, 2021 at 10:58 am PT
Reply(1)
The Los Gatos Town Council takes public comment during a discussion of hate crimes Tuesday. (Screenshot from Town of Los Gatos Council Meeting )
LOS GATOS, CA The Los Gatos Town Council Tuesday intended to discuss the recent rise in hate crimes aimed at Asians and Asian Americans, but its meeting turned into an unexpected gripe session by supporters of former President Donald Trump.
The meeting took place a week after someone shoved a woman of Filipino descent to the ground while she walked in Los Gatos and told her to go back to [expletive] China. It was the latest in a rising spate of hate crimes and incidents targeting Asian Americans in the Bay Area and around the country. ....

Province Of Zamboanga Sibugay , United States , Melanie Aron , Los Gatos , Councilmember Maria Ristow , Donald Trump , Marico Sayoc , Councilmember Matthew Hudes , Jeff Rosen , Town Of Los Gatos Council Meeting , Los Gatos Town Council , Cities Association Of Santa Clara , Patch Staff Badge , Los Gatos Council Meeting , Los Gatos Town Council Tuesday , Asian Americans , President Donald , Bay Area , Clara County District Attorney Jeff Rosen , Mayor Marico Sayoc , Epoch Times , Rabbi Melanie Aron , Cities Association , Santa Clara , Twitter Wednesday , Councilmember Maria ,

Aridis Pharmaceuticals Provides Multiple Program Updates Including the Addition of a Second Inhaled Antibody to Neutralize Newly Emerging COVID-19 Mutated Variants


Share this article
Share this article
LOS GATOS, Calif., Feb. 23, 2021 /PRNewswire/  Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, announced today that it has augmented its inhaled AR-711 monoclonal antibody (mAb) to COVID-19 with a second mAb (AR-713) that is designed to neutralize newly emerging COVID-19 mutated variants including those from South Africa, Brazil and Japan. Together, the enhanced dual antibody cocktail will be delivered as an inhaled treatment and is expected to provide broad coverage of all known high-risk strains. In addition, Aridis is pleased to announce preclinical development services support from NIAID. The preclinical development services support is also provided by the Coronavirus Immunotherapy Consortium (CoVIC). Aridis is on track to initiate the program s Phase 1/2/3 clinical trial in 2H 2021. ....

United States , United Kingdom , South Africa , South African , Jason Wong , Vu Truong , University Of Alabama Birmingham , National Institute Of Allergy , Aridis Pharmaceuticals , Aridis Pharmaceuticals Inc , Melinda Gates Foundation , Covic Consortium , United States Department Of Health , Texas Biomedical Research Institute , National Institutes Of Health , Human Services , Blueprint Life Science Group , Exchange Commission , Coronavirus Immunotherapy Consortium Co , Chief Executive Officer , Texas Biomedical Research , National Institute , Infectious Diseases , National Institutes , United States Department , Wellcome Trust ,